FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229884312> ?p ?o ?g. }

• W4229884312 abstract "<sec> <title>BACKGROUND</title> Drug development is still a costly and time-consuming process with a low rate of success. Drug repurposing (DR) has attracted significant attention because of its significant advantages over traditional approaches in terms of development time, cost, and safety. Entitymetrics, defined as bibliometric indicators based on biomedical entities (eg, diseases, drugs, and genes) studied in the biomedical literature, make it possible for researchers to measure knowledge evolution and the transfer of drug research. </sec> <sec> <title>OBJECTIVE</title> The purpose of this study was to understand DR from the perspective of biomedical entities (diseases, drugs, and genes) and their evolution. </sec> <sec> <title>METHODS</title> In the work reported in this paper, we extended the bibliometric indicators of biomedical entities mentioned in PubMed to detect potential patterns of biomedical entities in various phases of drug research and investigate the factors driving DR. We used aspirin (acetylsalicylic acid) as the subject of the study since it can be repurposed for many applications. We propose 4 easy, transparent measures based on entitymetrics to investigate DR for aspirin: Popularity Index (P₁), Promising Index (P₂), Prestige Index (P₃), and Collaboration Index (CI). </sec> <sec> <title>RESULTS</title> We found that the maxima of P₁, P₃, and CI are closely associated with the different repurposing phases of aspirin. These metrics enabled us to observe the way in which biomedical entities interacted with the drug during the various phases of DR and to analyze the potential driving factors for DR at the entity level. P₁ and CI were indicative of the dynamic trends of a specific biomedical entity over a long time period, while P₂ was more sensitive to immediate changes. P₃ reflected the early signs of the practical value of biomedical entities and could be valuable for tracking the research frontiers of a drug. </sec> <sec> <title>CONCLUSIONS</title> In-depth studies of side effects and mechanisms, fierce market competition, and advanced life science technologies are driving factors for DR. This study showcases the way in which researchers can examine the evolution of DR using entitymetrics, an approach that can be valuable for enhancing decision making in the field of drug discovery and development. </sec>" @default.
• W4229884312 created "2022-05-11" @default.
• W4229884312 creator A5026263464 @default.
• W4229884312 creator A5045749444 @default.
• W4229884312 creator A5047170063 @default.
• W4229884312 creator A5054734866 @default.
• W4229884312 creator A5072295375 @default.
• W4229884312 date "2019-10-19" @default.
• W4229884312 modified "2023-09-28" @default.
• W4229884312 title "Understanding Drug Repurposing From the Perspective of Biomedical Entities and Their Evolution: Bibliographic Research Using Aspirin (Preprint)" @default.
• W4229884312 cites W1519541746 @default.
• W4229884312 cites W1527927437 @default.
• W4229884312 cites W1555254253 @default.
• W4229884312 cites W1602102908 @default.
• W4229884312 cites W1975551833 @default.
• W4229884312 cites W1976829395 @default.
• W4229884312 cites W1981587917 @default.
• W4229884312 cites W1982945330 @default.
• W4229884312 cites W1983759759 @default.
• W4229884312 cites W1985270532 @default.
• W4229884312 cites W1995580819 @default.
• W4229884312 cites W2001575358 @default.
• W4229884312 cites W2005706129 @default.
• W4229884312 cites W2008574207 @default.
• W4229884312 cites W2011726136 @default.
• W4229884312 cites W2011833590 @default.
• W4229884312 cites W2018518196 @default.
• W4229884312 cites W2019543926 @default.
• W4229884312 cites W2020132970 @default.
• W4229884312 cites W2026958150 @default.
• W4229884312 cites W2027538725 @default.
• W4229884312 cites W2032739348 @default.
• W4229884312 cites W2041729187 @default.
• W4229884312 cites W2045913143 @default.
• W4229884312 cites W2046448117 @default.
• W4229884312 cites W2053403152 @default.
• W4229884312 cites W2054473834 @default.
• W4229884312 cites W2063149926 @default.
• W4229884312 cites W2063181146 @default.
• W4229884312 cites W2068330569 @default.
• W4229884312 cites W2083225388 @default.
• W4229884312 cites W2084292968 @default.
• W4229884312 cites W2092252523 @default.
• W4229884312 cites W2094555175 @default.
• W4229884312 cites W2112600921 @default.
• W4229884312 cites W2117694083 @default.
• W4229884312 cites W2119551670 @default.
• W4229884312 cites W2134783591 @default.
• W4229884312 cites W2135467896 @default.
• W4229884312 cites W2136486607 @default.
• W4229884312 cites W2144267044 @default.
• W4229884312 cites W2145578524 @default.
• W4229884312 cites W2157632574 @default.
• W4229884312 cites W2167212630 @default.
• W4229884312 cites W2169344707 @default.
• W4229884312 cites W2215595606 @default.
• W4229884312 cites W2316160054 @default.
• W4229884312 cites W2336207313 @default.
• W4229884312 cites W2399179461 @default.
• W4229884312 cites W2468923916 @default.
• W4229884312 cites W2498583968 @default.
• W4229884312 cites W2514790758 @default.
• W4229884312 cites W2533611849 @default.
• W4229884312 cites W2557791612 @default.
• W4229884312 cites W2598265731 @default.
• W4229884312 cites W2604527271 @default.
• W4229884312 cites W2614356214 @default.
• W4229884312 cites W2734505834 @default.
• W4229884312 cites W2752901244 @default.
• W4229884312 cites W2759136286 @default.
• W4229884312 cites W2770261575 @default.
• W4229884312 cites W2775714759 @default.
• W4229884312 cites W2783293389 @default.
• W4229884312 cites W2784280150 @default.
• W4229884312 cites W2785947426 @default.
• W4229884312 cites W2807463161 @default.
• W4229884312 cites W2807625293 @default.
• W4229884312 cites W2810917884 @default.
• W4229884312 cites W2887932365 @default.
• W4229884312 cites W2890437808 @default.
• W4229884312 cites W2899349918 @default.
• W4229884312 cites W2902774017 @default.
• W4229884312 cites W2922024285 @default.
• W4229884312 cites W2928195564 @default.
• W4229884312 cites W2951714618 @default.
• W4229884312 cites W2954442758 @default.
• W4229884312 cites W3015167373 @default.
• W4229884312 cites W4238029337 @default.
• W4229884312 doi "https://doi.org/10.2196/preprints.16739" @default.
• W4229884312 hasPublicationYear "2019" @default.
• W4229884312 type Work @default.
• W4229884312 citedByCount "0" @default.
• W4229884312 crossrefType "posted-content" @default.
• W4229884312 hasAuthorship W4229884312A5026263464 @default.
• W4229884312 hasAuthorship W4229884312A5045749444 @default.
• W4229884312 hasAuthorship W4229884312A5047170063 @default.
• W4229884312 hasAuthorship W4229884312A5054734866 @default.
• W4229884312 hasAuthorship W4229884312A5072295375 @default.
• W4229884312 hasBestOaLocation W42298843122 @default.
• W4229884312 hasConcept C103637391 @default.

• next